SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,581.63 11.28
( 0.01%)

Global Indices

Nasdaq

53,087.25 299.37
(0.57%)

Dow Jones

7,688.45 35.98
(0.47%)

Hang Seng

64,337.38 11.74
(0.02%)

Nikkei 225

10,761.93 -27.35
(-0.25%)

Forex

USD-INR

94.95 -0.29
(-0.30%)

EUR-INR

110.11 -0.38
(-0.35%)

GBP-INR

128.48 -0.52
(-0.40%)

JPY-INR

0.59 0.00
(-0.47%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

285.6722314

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

20.58

16239.06

EPS(TTM)

Face Value()

Div & Yield %

40.14

1.45

Back

swadha nature ltd

Caprihans India reports consolidated net profit of Rs 6.22 crore in the June 2026 quarter

Aug 11,2026

Net profit of Caprihans India reported to Rs 6.22 crore in the quarter ended June 2026 as against net loss of Rs 13.56 crore during the previous quarter ended June 2025. Sales rose 22.68% to Rs 218.19 crore in the quarter ended June 2026 as against Rs 177.85 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	218.19	177.85	23
OPM %	15.50	5.23	-
PBDT	16.98	-6.73	LP
PBT	6.22	-17.66	LP
NP	6.22	-13.56	LP

76,581.63 11.28 ( 0.01%)

53,087.25 299.37 (0.57%)

7,688.45 35.98 (0.47%)

64,337.38 11.74 (0.02%)

10,761.93 -27.35 (-0.25%)

94.95 -0.29 (-0.30%)

110.11 -0.38 (-0.35%)

128.48 -0.52 (-0.40%)

0.59 0.00 (-0.47%)